New obesity drug AMG 786 enters early safety testing
NCT ID NCT05406115
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 27 times
Summary
This early-stage study tested a new drug called AMG 786 in 65 healthy adults and people with obesity. The main goal was to check if the drug is safe and how the body processes it. Researchers gave single or multiple doses and monitored for side effects. This is a first step to see if the drug might help with weight management.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Pharmacology of Miami, LLC
Miami, Florida, 33014, United States
-
Orange County Research Center
Tustin, California, 92780, United States
-
Translational Clinical Research LLC
Aventura, Florida, 33180, United States
Conditions
Explore the condition pages connected to this study.